Protéasome
Les inhibiteurs du protéasome sont des composés qui inhibent le protéasome, un grand complexe protéique responsable de la dégradation des protéines indésirables ou endommagées dans la cellule. L'inhibition du protéasome conduit à l'accumulation de protéines, ce qui peut induire l'arrêt du cycle cellulaire et l'apoptose, en particulier dans les cellules à division rapide comme les cellules cancéreuses. Les inhibiteurs du protéasome sont essentiels dans la recherche sur le cancer et la thérapie, en particulier dans le traitement du myélome multiple et d'autres hémopathies malignes. Chez CymitQuimica, nous proposons des inhibiteurs du protéasome pour soutenir vos recherches en oncologie, biologie cellulaire et développement de médicaments.
94 produits trouvés pour "Protéasome"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Proteasome-IN-5
CAS :<p>Proteasome-IN-5, also known as compound 5, acts as a proteasome inhibitor [1].</p>Formule :C20H30BN5O7Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :463.29Proteasome β2c/i-IN-1
CAS :<p>Proteasome β2c/i-IN-1 (compound 37) serves as a selective inhibitor targeting the β2c and β2i subunits of the human proteasome [1].</p>Formule :C32H48N4O7Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :600.75LU-002i
CAS :<p>LU-002i is a selective inhibitor targeting the human proteasome subunits β2c and β2i, demonstrating an inhibitory concentration (IC50) of 220 nM for β2i [1].</p>Formule :C35H52N4O7Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :640.81TCL1
CAS :<p>TCL1 acts as a selective non-covalent inhibitor targeting the Pru domain of the Rpn-13 subunit within the 19S regulatory particle (19S RP) of the proteasome, with an IC50 value around 26 μM. It disrupts the recognition and transport of ubiquitinated proteins by Rpn-13, thus inhibiting proteasomal degradation and affecting intracellular protein metabolism balance. TCL1 holds potential for research in hematologic malignancies.</p>Formule :C19H14BrClN4O2SCouleur et forme :SolidMasse moléculaire :477.762ZINC09518833
CAS :<p>ZINC09518833 is an α-ketoamide non-peptide proteasome inhibitor with an IC50 value of 12.4 μM. It can bind with both the active and inactive sites of the proteasome. ZINC09518833 shows promise for use in research related to multiple myeloma (MM).</p>Formule :C24H25N3O5Couleur et forme :SolidMasse moléculaire :435.47RBx-0597
CAS :<p>RBx-0597 is a selective DPP-IV inhibitor with IC50 values of 32 nM, 31 nM, and 39 nM for human, mouse, and rat plasma DPP-IV, respectively. It is utilized in research focused on type 2 diabetes.</p>Formule :C19H20F2N4O2Couleur et forme :SolidMasse moléculaire :374.384(2S,4R)-Teneligliptin
CAS :<p>(2S,4R)-Teneligliptin is a selective inhibitor of dipeptidyl peptidase IV (DPP-4). It increases the concentration of active glucagon-like peptide-1 (GLP-1) in plasma, which in turn stimulates insulin secretion when blood glucose levels are elevated, thereby exhibiting hypoglycemic effects. (2S,4R)-Teneligliptin is a promising candidate for research in type 2 diabetes.</p>Formule :C22H30N6OSCouleur et forme :SolidMasse moléculaire :426.578DPP-4-IN-15
CAS :<p>DPP-4-IN-15 (Compound 22) is a non-competitive inhibitor of dipeptidyl peptidase-4 (DPP-4) with an IC50 value of 8.24 μM.</p>Formule :C17H14F3N3O2SCouleur et forme :SolidMasse moléculaire :381.372Boc3Arg
<p>Boc 3 Arg is a tert-butyl carbamate-protected arginine compound. It serves as an efficient tag that induces degradation by directly targeting proteins to the 20S proteasome.</p>Formule :C21H39N5O7Couleur et forme :SolidMasse moléculaire :473.56Marizomib
CAS :<p>Marizomib is a novel irreversible brain-permeable proteasome inhibitor that inhibits CT-L, CT-T-laspase-like, and trypsin-like 20S proteasomes.Cost-effective and quality-assured.</p>Formule :C15H20ClNO4Degré de pureté :98.03% - 99.41%Couleur et forme :SolidMasse moléculaire :313.78Immunoproteasome activator 1
CAS :Immunoproteasome Activator 1 (compound A) is a selective immunoproteasome activator that enhances the presentation of individual MHC-I binding peptides by over 100 times. It binds to the proteasomal structural subunit PSMA1 and facilitates the association of the proteasome activators PA28α/β (PSME1/PSME2) with the immunoproteasome.Formule :C24H23N3O3Couleur et forme :SolidMasse moléculaire :401.46PB01
CAS :<p>PB01 is a DPP-4 inhibitor with an IC50 of 15.66 nM. It effectively suppresses high glucose-induced ROS generation and mitochondrial superoxide production while significantly reducing the cellular expression of DPP-4. Additionally, PB01 notably lowers blood glucose levels in diabetic mice. It demonstrates excellent safety, exhibiting almost no cytotoxicity at a concentration of 100 μM. PB01 holds promise for research in the diabetes field.</p>Formule :C18H21N5O3Couleur et forme :SolidMasse moléculaire :355.391BI-1942
CAS :<p>BI-1942 is a chymase inhibitor with an IC50 value of 0.4 nM against human chymase. It is applicable for research in ophthalmic diseases.</p>Formule :C24H26N4O4Couleur et forme :SolidMasse moléculaire :434.488Davelizomib
CAS :<p>Davelizomib is a proteasome inhibitor that exhibits antineoplastic activity [1].</p>Formule :C21H26BF2N3O7Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :481.25
